Sign Out
Pregnancy: The data, that are available from the use of ciprofloxacin in pregnant women, indicate neither malformative nor feto/neonatal toxicity. Animal studies do not indicate reproductive toxicity. Based on animal studies, it cannot be excluded that the drug could cause damage to articular cartilage in the immature fetal organism (see Pharmacology: Toxicology: Preclinical safety data under Actions), therefore, the use of Ciprofloxacin (Ciprobay) is not recommended during pregnancy.
Animal studies have not shown any evidence of teratogenic effects (malformations) (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Lactation: Ciprofloxacin is excreted in breast milk. Due to the potential risk of articular damage, the use of Ciprofloxacin (Ciprobay) is not recommended during breast-feeding (see Pharmacology: Toxicology: Preclinical safety data under Actions).
